Sort by
Keyphrases
Contrast Enhancement
100%
Doxorubicin-induced Cardiotoxicity
100%
Functional Events
100%
Integrated Characterization
100%
Left Ventricular Ejection Fraction
66%
Cardiac Troponin
66%
Left Ventricular Dysfunction
66%
Cardiomyocytes
66%
Two-dose
66%
Cardiac Magnetic Resonance Imaging (cMRI)
66%
Functional Indices
66%
Electron Microscopy
33%
Doxorubicin
33%
Cancer Treatment
33%
Statistical Significance
33%
Recovery Period
33%
Early Markers
33%
Wistar Rats
33%
Hypertrophy
33%
Rat Model
33%
Histological Grade
33%
Troponin
33%
Cardiac Output
33%
Myocardium
33%
Histological Analysis
33%
Hanover
33%
Vacuolation
33%
Comprehensive Characterization
33%
Diastolic Dysfunction
33%
Cardiac Morbidity
33%
Multiple Approaches
33%
Predictive Biomarker
33%
Functional Decline
33%
Mitochondrial Alterations
33%
Replacement Fibrosis
33%
Sirius Red Staining
33%
Early Damage
33%
Karyomegaly
33%
Biomarker Index
33%
Doxorubicin-induced Cardiomyopathy
33%
Gadolinium Contrast
33%
Medicine and Dentistry
Doxorubicin
100%
Troponin I
100%
Cardiotoxicity
100%
Biological Marker
66%
Heart Left Ventricle Ejection Fraction
66%
Cardiac Troponin
66%
Cardiac Magnetic Resonance Imaging
66%
Cardiac Muscle Cell
66%
Electron Microscopy
33%
Single Drug Dose
33%
Fibrosis
33%
Myocardium
33%
Heart Output
33%
Cancer Therapy
33%
Vacuolization
33%
Diastolic Dysfunction
33%
Gadolinium
33%
Myocardial Disease
33%
E/A Ratio
33%
Cytomegaly
33%
Biochemistry, Genetics and Molecular Biology
Troponin I
100%
Doxorubicin
100%
Contrast Enhancement
100%
Heart Left Ventricle Ejection Fraction
66%
Cardiac Troponin
66%
Cardiac Muscle Cell
66%
Magnetic Resonance Imaging
66%
Electron Microscopy
33%
Rat Model
33%
Heart Output
33%
Single Drug Dose
33%
Gadolinium
33%
Wistar Hannover Rat
33%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cardiotoxicity
100%
Troponin I
100%
Biological Marker
66%
Malignant Neoplasm
33%
Rat Model
33%
Fibrosis
33%
Electron Microscopy
33%
Gadolinium
33%
Diastolic Dysfunction
33%
Myocardial Disease
33%
Wistar Hannover Rat
33%
Cytomegaly
33%